Literature DB >> 19650945

The 2007 GOLD Guidelines: a comprehensive care framework.

Philip M Gold1.   

Abstract

Comprehensive management of chronic obstructive pulmonary disease (COPD) includes proper assessment, monitoring of disease, reduction of risk factors, the management of stable COPD, and the prevention and management of exacerbations. The 2007 COPD guidelines from the Global Initiative for Chronic Obstructive Lung Disease address each of these aspects of COPD management in detail and provide evidence-based recommendations for patients and health-care professionals. Reduction of risk factors emphasizes the importance of smoking cessation and control of environmental indoor and outdoor pollutants. The management of COPD must be individualized. Aerosol administration of bronchodilators is the most effective method of reducing the work of breathing and alleviating dyspnea. Glucocorticosteroid therapy is recommended to reduce the frequency of exacerbations and improve health-related quality of life for patients with stage 3 and 4 COPD. Pulmonary rehabilitation proves effective in relieving symptoms, improving quality of life, and increasing patients' physical and emotional participation in activities of daily life. Oxygen therapy is essential for patients with substantial hypoxia. Patients with COPD and respiratory failure may benefit from noninvasive ventilation. Surgery may play a limited role in the management of selected patients with COPD. Since exacerbations influence lung function and clinical decline in patients with COPD and contribute to the cost of caring for this disease, efforts must be directed at prevention and management of exacerbations. In addition to controlled oxygen therapy, antimicrobials, brief courses of systemic corticosteroids and, on occasion, noninvasive or invasive mechanical ventilation may play a role. The role of respiratory therapists in the prevention, diagnosis, and management of stable COPD and exacerbations is absolutely essential if the goals of the 2007 Global Initiative for Chronic Obstructive Lung Disease guidelines are to be attained.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19650945

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  44 in total

1.  Clinical validation of a risk scale for serious outcomes among patients with chronic obstructive pulmonary disease managed in the emergency department.

Authors:  Ian G Stiell; Jeffrey J Perry; Catherine M Clement; Robert J Brison; Brian H Rowe; Shawn D Aaron; Andrew D McRae; Bjug Borgundvaag; Lisa A Calder; Alan J Forster; Jennifer Brinkhurst; George A Wells
Journal:  CMAJ       Date:  2018-12-03       Impact factor: 8.262

2.  Glucose and pyruvate metabolism in severe chronic obstructive pulmonary disease.

Authors:  Christina C Kao; Jean W-C Hsu; Venkata Bandi; Nicola A Hanania; Farrah Kheradmand; Farook Jahoor
Journal:  J Appl Physiol (1985)       Date:  2011-10-20

3.  Predictive score for mortality in patients with COPD exacerbations attending hospital emergency departments.

Authors:  José M Quintana; Cristóbal Esteban; Anette Unzurrunzaga; Susana Garcia-Gutierrez; Nerea Gonzalez; Irantzu Barrio; Inmaculada Arostegui; Iratxe Lafuente; Marisa Bare; Nerea Fernandez-de-Larrea; Silvia Vidal
Journal:  BMC Med       Date:  2014-04-23       Impact factor: 8.775

Review 4.  Noninvasive positive pressure ventilation for chronic respiratory failure patients with stable chronic obstructive pulmonary disease (COPD): an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2012-03-01

5.  Ticagrelor versus genotype-driven antiplatelet therapy for secondary prevention after acute coronary syndrome: a cost-effectiveness analysis.

Authors:  Daniel J Crespin; Jerome J Federspiel; Andrea K Biddle; Daniel E Jonas; Joseph S Rossi
Journal:  Value Health       Date:  2011-05-19       Impact factor: 5.725

6.  Environmental allergies and respiratory morbidities in cystic fibrosis.

Authors:  Joseph M Collaco; Christopher B Morrow; Deanna M Green; Garry R Cutting; Peter J Mogayzel
Journal:  Pediatr Pulmonol       Date:  2012-11-09

7.  A decision tree to assess short-term mortality after an emergency department visit for an exacerbation of COPD: a cohort study.

Authors:  Cristóbal Esteban; Inmaculada Arostegui; Susana Garcia-Gutierrez; Nerea Gonzalez; Iratxe Lafuente; Marisa Bare; Nerea Fernandez de Larrea; Francisco Rivas; José M Quintana
Journal:  Respir Res       Date:  2015-12-22

Review 8.  Level of daily physical activity in individuals with COPD compared with healthy controls.

Authors:  Sigrid N W Vorrink; Helianthe S M Kort; Thierry Troosters; Jan-Willem J Lammers
Journal:  Respir Res       Date:  2011-03-22

9.  Effects of Integrated Case Payment on Medical Expenditure and Readmission of Inpatients with Chronic Obstructive Pulmonary Disease: A Nonrandomized, Comparative Study in Xi County, China.

Authors:  Meng Shi; Jing Wang; Liang Zhang; Yan Yan; Yu-Dong Miao; Xiang Zhang
Journal:  Curr Med Sci       Date:  2018-06-22

10.  Treating viral exacerbations of chronic obstructive pulmonary disease: insights from a mouse model of cigarette smoke and H1N1 influenza infection.

Authors:  Carla M T Bauer; Caleb C J Zavitz; Fernando M Botelho; Kristen N Lambert; Earl G Brown; Karen L Mossman; John D Taylor; Martin R Stämpfli
Journal:  PLoS One       Date:  2010-10-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.